Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma

World Journal of Gastroenterology

Volumn 11, Issue 43, 2005, Pages 6765-6769

  Jeong, Seok ^a   Lee, Don Haeng ^a   Lee, Jung Il ^a   Lee, Jin Woo ^a   Kwon, Kye Sook ^a   Kim, Pum Soo ^a   Kim, Hyung Gil ^a   Shin, Yong Woon ^a   Kim, Young Soo ^a   Kim, Young Bae ^b  

^a Inha University School of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Chronic pancreatitis; K ras; Ki 67; p53; Pancreatic ductal adenocarcinoma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; K RAS PROTEIN; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREAS ISLET CELL HYPERPLASIA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR CLASSIFICATION;

EID: 30744476492     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i43.6765     Document Type: Article

References (24)

1. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992; 326: 455-465
2. Boyle P, Hsieh CC, Maisonneuve P, La Vecchia C, Macfarlane GJ, Walker AM, Trichopoulos D. Epidemiology of pancreas cancer (1988). Int J Pancreatol 1989; 5: 327-346
3. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995; 45: 8-30
4. Crist DW, Cameron JL. The current status of the Whipple operation for periampullary carcinoma. Adv Surg 1992; 25: 21-49
5. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andren-Sandberg A, Domellof L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993; 328: 1433-1437
6. Cubilla AL, Fitzgerald PJ. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 1976; 36: 2690-2698
7. Kozuka S, Sassa R, Taki T, Masamoto K, Nagasawa S, Saga S, Hasegawa K, Takeuchi M. Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979; 43: 1418-1428
8. SOMMERS SC, MURPHY SA, WARREN S. Pancreatic duct hyperplasia and cancer. Gastroenterology 1954; 27: 629-640
9. Apple SK, Hecht JR, Lewin DN, Jahromi SA, Grody WW, Nieberg RK .Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis. Hum Pathol 1999; 30: 123-129
10. Kloppel G. Pancreatic Pathology. Edinburg, Scotland: Churchill Livingstone, 1984: 79-113
11. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767
12. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532
13. Chen J, Baithun SI, Ramsay MA. Histogenesis of pancreatic carcinomas: a study based on 248 cases. J Pathol 1985; 146: 65-76
14. Kloppel G. The pancreas: biology, pathobiology, and disease. 2nd ed. New York: Raven Press, 1993: 871-898
15. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878
16. DiGiuseppe JA, Hruban RH, Goodman SN, Polak M, van den Berg FM, Allison DC, Cameron JL, Offerhaus GJ. Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 1994; 101: 684-688
17. Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani GN. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994; 54: 1556-1560
18. Yokoyama M, Yamanaka Y, Friess H, Buchler M, Korc M. p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness. Anticancer Res 1994; 14: 2477-2483
19. Sakorafas GH, Lazaris A, Tsiotou AG, Koullias G, Glinatsis MT, Golematis BC. Oncogenes in cancer of the pancreas. Eur J Surg Oncol 1995; 21: 251-253
20. Berrozpe G, Schaeffer J, Peinado MA, Real FX, Perucho M. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int J Cancer 1994; 58: 185-191
21. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinoma of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53: 549-554
22. Motojima K, Tsunoda T, Kanematsu T, Nagata Y, Urano T, Shiku H. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Ann Surg 1991; 214: 657-662
23. Motojima K, Urano T, Nagata Y, Shiku H, Tsurifune T, Kanematsu T. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann Surg 1993; 217: 138-143
24. Tabata T, Fujimori T, Maeda S, Yamamoto M, Saitoh Y. The role of Ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int J Pancreatol 1993; 14: 237-244